These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29467665)

  • 1. Analysis of microRNA Expression Profiles Induced by Yiqifumai Injection in Rats with Chronic Heart Failure.
    Zhao Y; Li Y; Tong L; Liang X; Zhang H; Li L; Fan G; Wang Y
    Front Physiol; 2018; 9():48. PubMed ID: 29467665
    [No Abstract]   [Full Text] [Related]  

  • 2. YiQiFuMai powder injection ameliorates chronic heart failure through cross-talk between adipose tissue and cardiomyocytes via up-regulation of circulating adipokine omentin.
    Li F; Pang LZ; Zhang L; Zhang Y; Zhang YY; Yu BY; Kou JP
    Biomed Pharmacother; 2019 Nov; 119():109418. PubMed ID: 31505423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YiQiFuMai Powder Injection Attenuates Ischemia/Reperfusion-Induced Myocardial Apoptosis Through AMPK Activation.
    Li F; Zheng X; Fan X; Zhai K; Tan Y; Kou J; Yu B
    Rejuvenation Res; 2016 Dec; 19(6):495-508. PubMed ID: 27072567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YiQiFuMai Powder Injection attenuates coronary artery ligation-induced myocardial remodeling and heart failure through modulating MAPKs signaling pathway.
    Pang LZ; Ju AC; Zheng XJ; Li F; Song YF; Zhao Y; Gu YF; Chen FL; Liu CH; Qi J; Gao Z; Kou JP; Yu BY
    J Ethnopharmacol; 2017 Apr; 202():67-77. PubMed ID: 28237302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective effects of the YiQiFuMai injection and isolated compounds on attenuating chronic heart failure via NF-κB inactivation and cytokine suppression.
    Xing L; Jiang M; Dong L; Gao J; Hou Y; Bai G; Luo G
    J Ethnopharmacol; 2013 Jun; 148(1):239-45. PubMed ID: 23619019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injection of YiQiFuMai powder protects against heart failure via inhibiting p38 and ERK1/2 MAPKs activation.
    Nie Y; Zhang Y; Li Z; Wan M; Li D
    Pharm Biol; 2022 Dec; 60(1):570-578. PubMed ID: 35244521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YiQiFuMai Powder Injection Attenuates Coronary Artery Ligation-Induced Heart Failure Through Improving Mitochondrial Function via Regulating ROS Generation and CaMKII Signaling Pathways.
    Zhang Y; Zhang L; Zhang Y; Fan X; Yang W; Yu B; Kou J; Li F
    Front Pharmacol; 2019; 10():381. PubMed ID: 31031629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic Analysis Reveals the Protective Effects of Yiqi Fumai Lyophilized Injection on Chronic Heart Failure by Improving Myocardial Energy Metabolism.
    Han X; Zhang Y; Qiao O; Ji H; Zhang X; Wang W; Li X; Wang J; Li D; Ju A; Liu C; Gao W
    Front Pharmacol; 2021; 12():719532. PubMed ID: 34630097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
    Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
    Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YIQIFUMAI INJECTION AMELIORATED SEPSIS-INDUCED CARDIOMYOPATHY BY INHIBITION OF FERROPTOSIS VIA XCT/GPX4 AXIS.
    Guo L; Li P; Wang Y; Wang J; Lei J; Zhao J; Wu X; He W; Jia J; Miao J; Wang D; Cui H
    Shock; 2024 Apr; 61(4):638-645. PubMed ID: 37983962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YiQiFuMai Powder Injection ameliorates the oxygen-glucose deprivation-induced brain microvascular endothelial barrier dysfunction associated with the NF-κB and ROCK1/MLC signaling pathways.
    Cao GS; Chen HL; Zhang YY; Li F; Liu CH; Xiang X; Qi J; Chai CZ; Kou JP; Yu BY
    J Ethnopharmacol; 2016 May; 183():18-28. PubMed ID: 26915982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yiqi Fumai Injection as an Adjuvant Therapy in Treating Chronic Heart Failure: A Meta-Analysis of 33 Randomized Controlled Trials.
    Nie H; Li S; Liu M; Zhu W; Zhou X; Yan D
    Evid Based Complement Alternat Med; 2020; 2020():1876080. PubMed ID: 32922505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YiQiFuMai Powder Injection Protects against Ischemic Stroke via Inhibiting Neuronal Apoptosis and PKC
    Xu Y; Wang Y; Wang G; Ye X; Zhang J; Cao G; Zhao Y; Gao Z; Zhang Y; Yu B; Kou J
    Oxid Med Cell Longev; 2017; 2017():1832093. PubMed ID: 29435096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated pharmacokinetics of ginsenosides after intravenous administration of YiQiFuMai powder injection in rats with chronic heart failure by UFLC-MS/MS.
    Zheng HR; Chu Y; Zhou DZ; Ju AC; Li W; Li X; Xia Y; Polachi N; Li DK; Zhou SP; Sun H; Liu CX
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():282-289. PubMed ID: 29202359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YiQiFuMai Powder Injection Ameliorates Cerebral Ischemia by Inhibiting Endoplasmic Reticulum Stress-Mediated Neuronal Apoptosis.
    Cao G; Zhou H; Jiang N; Han Y; Hu Y; Zhang Y; Qi J; Kou J; Yu B
    Oxid Med Cell Longev; 2016; 2016():5493279. PubMed ID: 27087890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YiQiFuMai powder injection ameliorates blood-brain barrier dysfunction and brain edema after focal cerebral ischemia-reperfusion injury in mice.
    Cao G; Ye X; Xu Y; Yin M; Chen H; Kou J; Yu B
    Drug Des Devel Ther; 2016; 10():315-25. PubMed ID: 26834461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YiQiFuMai lyophilized injection attenuates particulate matter-induced acute lung injury in mice via TLR4-mTOR-autophagy pathway.
    Xia Y; S D; Jiang S; Fan R; Wang Y; Wang Y; Tang J; Zhang Y; He RL; Yu B; Kou J
    Biomed Pharmacother; 2018 Dec; 108():906-913. PubMed ID: 30372902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemical components, action mechanisms, and clinical evidences of YiQiFuMai injection in the treatment of heart failure.
    Lv S; Wang Y; Zhang W; Shang H
    Front Pharmacol; 2022; 13():1040235. PubMed ID: 36506553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effects of Aconiti Lateralis Radix Praeparata combined with Zingiberis Rhizoma on doxorubicin-induced chronic heart failure in rats and potential mechanisms.
    Wen J; Zou W; Wang R; Liu H; Yang Y; Li H; Wei S; Li R; Cai H; Wang J; Zhao Y
    J Ethnopharmacol; 2019 Jun; 238():111880. PubMed ID: 31004728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-200a-3p Is a Positive Regulator in Cardiac Hypertrophy Through Directly Targeting WDR1 as Well as Modulating PTEN/PI3K/AKT/CREB/WDR1 Signaling.
    Yang X; Chen G; Chen Z
    J Cardiovasc Pharmacol; 2019 Nov; 74(5):453-461. PubMed ID: 31651553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.